Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers

BACKGROUND: Serum levels of a secreted glycoprotein YKL-40 are elevated in patients with a wide range of cancers including breast, colorectal, and ovarian cancers. Furthermore, these increased levels correlate with poorer survival of cancer patients, suggesting that serum levels of YKL-40 might be a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, R, Cao, Q J, Arenas, R B, Bigelow, C, Bentley, B, Yan, W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208489/
https://www.ncbi.nlm.nih.gov/pubmed/21934681
http://dx.doi.org/10.1038/bjc.2011.347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208489/
https://www.ncbi.nlm.nih.gov/pubmed/21934681
http://dx.doi.org/10.1038/bjc.2011.347

Ejemplares similares